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Objective: To determine 5-year mortality and its association 
with baseline characteristics and functional status 6 months 
post-stroke for patients who received inpatient rehabilita-
tion.
Design: A prospective rehabilitation-based cohort study. 
Subjects: A total of 532 consecutive stroke patients from 4 
European rehabilitation centres.
Methods: Predictors were recorded on admission. Barthel 
Index was assessed at 6 months (BI6mths) and patients were 
followed for 5 years post-stroke. Survival probability was 
computed using Kaplan–Meier analysis and compared across 
3 BI6mths-classes (0–60, 65–90, 95–100) (log-rank test). Sig-
nificant independent predictors were determined using mul-
tivariate Cox regression analysis (hazard ratio (HR)). 
Results: Five-year cumulative risk of death was 29.12% 
(95% confidence interval (CI): 22.86–35.38). Age (HR = 1.06, 
95% CI: 1.04–1.09), cognitive impairment (HR = 1.77, 95% 
CI: 1.21–2.57), diabetes mellitus (HR = 1.68, 95% CI: 1.16–
2.41) and atrial fibrillation (HR = 1.52, 95% CI: 1.08–2.14) 
were independent predictors of increased mortality. Hy-
perlipidaemia (HR = 0.66, 95% CI: 0.46–0.94), and higher 
BI6mths (HR = 0.98, 95% CI: 0.97–0.99) were independent 
predictors of decreased mortality. Five-year survival prob-
ability was 0.85 (95% CI: 0.80–0.89) for patients in BI6mths-
class: 95–100, 0.72 (95% CI: 0.63–0.79) in BI6mths-class: 
65–90 and 0.50 (95% CI: 0.40–0.60) in BI6mths-class: 0–60 
(p < 0.0001). 
Conclusion: Nearly one-third of rehabilitation patients died 
during the first 5 years following stroke. Functional status at 
6 months was a powerful predictor of long-term mortality. 
Maximum functional independence at 6 months post-stroke 
should be promoted through medical interventions and re-
habilitation. Future studies are recommended to evaluate 
the direct effect of rehabilitation on long-term survival.
Key words: follow-up study; stroke; rehabilitation; prognosis; 
mortality.
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INTRODUCTION 
In the past decade, the rate and prognostic factors for long-
term mortality after stroke have been investigated in both 
community- and hospital-based studies. Cumulative mortality 
risk ranges from 5% to 28% at 1 month, 15% to 41% at 1 year, 
and 42% to 60% at 5 years post-stroke (1–10). Age (2, 3, 6, 
7, 9), diabetes mellitus (6, 7, 9), atrial fibrillation (3, 9, 10), 
stroke recurrence (3, 7) and severity (3, 10) are well-recognized 
independent predictors of long-term mortality after stroke. 
The long-term outcome of patients admitted to stroke re-
habilitation units (SRU) has received less attention (11, 12). 
Lincoln et al. (11) reported 5-year mortality rates of 45% in 
176 patients treated on a SRU, compared with 55% in 139 
patients treated on conventional wards. For 110 patients treated 
in combined acute and rehabilitation wards, Indredavik et al. 
(12) reported 5-year mortality rate of 59% vs 71% for those 
in general wards. Studies investigating prognostic factors for 
long-term mortality in patients admitted to SRUs are lacking. 
Both from a clinical and economic point of view, knowledge 
of the prognostic factors for their long-term survival is of 
interest.
Results of both community- and hospital-based studies 
showed that functional outcome at 6 months post-stroke was 
associated with an increased risk of dying in the long term 
(9–13). It is unknown whether this association also applies to 
a stroke rehabilitation sample. For these patients, 6 months 
post-stroke is an important time-point. By then, the majority 
have been discharged from SRU and most motor and functional 
recovery has occurred (14).
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The aims of the study were: (i) to describe the mortality 
rate in the first 5 years after stroke in patients admitted to 4 
rehabilitation centres in europe; (ii) to determine the baseline 
prognostic factors for 5-year mortality post-stroke; (iii) to 
investigate the association between patients’ functional status 
at 6 months and their 5-year mortality. 
MeThODS
Patients and settings
This prospective cohort study is a follow-up of the Collaborative evalu-
ation of Rehabilitation in Stroke across europe (CeRISe) project. This 
project aimed to compare stroke care and recovery patterns between 
4 european rehabilitation centres (14): University hospital Leuven, 
Belgium; Nottingham University hospitals, Uk; RehaClinic Zurzach, 
Switzerland and Fachklinik herzogenaurach, germany. In each cen-
tre, inpatient multidisciplinary care was provided in a SRU. Between 
March 2002 and September 2004, patients were recruited consecutively 
using the following inclusion criteria: first-ever stroke as defined by 
the World health Organization (WhO) (15), age 40–85 years, and 
Rivermead Motor Assessment scores (16): Gross function ≤ 11, and/
or Leg and Trunk function ≤ 8 and/or Arm function ≤ 12 on admission 
to the centre. exclusion criteria were: other neurological impairments 
with permanent damage; stroke-like symptoms attributable to subdural 
haematoma, tumour, encephalitis or trauma; admission to the centre > 6 
weeks after stroke; no informed consent; and pre-stroke Barthel Index 
(BI) < 50. The BI consists of 10 items (continence of bowels and blad-
der, feeding, dressing, grooming, toilet use, bathing, mobility, stairs, 
transfer) that measure a person’s functional status. Scores range from 
0 to 100, with lower scores indicating more dependence (17).
Baseline assessment and follow-up
In the CeRISe project, a trained researcher in each SRU recorded 
the following 17 items on admission: age, gender, centre, never/ever 
smoked, type of stroke (ischaemic infarct, bleeding, unknown), ini-
tial BI, urinary incontinence (score < 10 on BI-bladder), swallowing 
problems (fluids must be thickened, diet must be modified, or patient 
requires non-oral feeding), aphasia (score > 0 on item 9 of the National 
Institute of health Stroke Scale (18) (NIhSS)), dysarthria (score 
> 0 on NIhSS-item 10), cognitive impairment (score > 0 on item 1b 
and/or 1c of the NIhSS), diabetes mellitus, history of hypertension 
(systolic blood pressure > 160 mmhg and/or diastolic blood pressure 
> 95 mmhg based on several measurements or on a 24-h recording 
and patients treated with anti-hypertensives), coronary heart disease, 
atrial fibrillation, history of myocardial infarction, hyperlipidaemia 
(total cholesterol > 200 mg/100 ml). At 6 months after stroke, BI was 
reassessed during clinical visits (BI6mths). 
In the present study, a researcher in each centre contacted all patients 
approximately 5 years after the initial stroke. In cases of death, the date 
of death was obtained from a family member, general practitioner, reg-
istry or hospital database. Data collection was spread over 1 year (June 
2008–2009). The researchers were familiarized with study protocol 
at a workshop. The project manager (LDW) visited each researcher 
to ensure standardized implementation of the research protocol. The 
study was approved by the ethics committee in each country.
Statistical analysis
patients’ characteristics are presented as means with standard devia-
tions (SD), medians with interquartile ranges (IQR), or frequencies 
with percentages, as appropriate. 
kaplan–Meier product limit techniques were used to generate mor-
tality probabilities at each consecutive year until 5 years after stroke. 
Survival times were censored at 5 years post-stroke. Cox regression 
analysis was used to examine the relationships between baseline vari-
ables and mortality over 5 years. The univariate relation was examined 
between all 17 baseline variables and mortality over 5 years. Alpha 
was set at 0.05. Multivariate analysis was then performed including 
all 17 baseline variables, regardless of their univariate significance. 
This full model approach was used because of the observational study 
design. We verified for multicollinearity by calculating variance infla-
tion factors (vIF). The square root of vIF indicates how much of the 
standard error of the estimate is increased due to multicollinearity 
compared with a situation where the covariates are uncorrelated. 
Results were presented as hazard ratio with 95% confidence intervals 
(hR (95% CI)). explained variance (R2: range: 0–100%) was calcu-
lated for all variables separately and for the full model according to 
Royston’s formula (19). To test the proportional hazard assumption, 
we verified the significance level of the interaction between each of 
the 17 baseline variables and time: only “initial BI × time” (p = 0.02), 
and “swallowing problems × time” (p = 0.04) proved significant in 
univariate, but not in multivariate analysis (p > 0.05). Therefore, both 
interaction terms were not retained in the final Cox regression model. 
In addition, there were no significant interactions between baseline 
variables and centre, indicating that a stratified Cox regression analysis 
per centre was not required.
Finally, the association between BI6mths and long-term mortality 
was examined using Cox regression analysis including only those pa-
tients for whom BI6mths was assessed. All 17 baseline variables were 
compared between patients who retained in the study and those who 
dropped out at 6 months. If BI6mths proved a significant univariate pre-
dictor, the association was further explored. Therefore, patients were 
divided into 3 classes based on their BI6mths score: 0–60, 65–90, and 
95–100. A cut-off of 60/100 was chosen, as the score of 60 is reported 
to be the cut-off point between independence and some dependence 
(20). Furthermore, patients are considered to be totally functionally 
independent when scoring ≥ 95/100 on the BI. Kaplan–Meier curves 
were calculated for each BI6mths class and compared using a log-rank 
test. Post-hoc pairwise class comparisons were carried out with a Šidák 
multiple testing correction. Finally, BI6mths was added to the baseline 
model to verify its multivariate association. All statistical analyses 
were carried out with SAS, version 9.2. 
Table I. Patients’ characteristics on admission to the rehabilitation 
centre (n = 532)
Age at stroke onset, years, mean (SD) 69.5 (10.3)
Barthel Index, median (quartile 1–3) 55 (30–80)
Female gender, n (%) 249 (46.8)
ever smoked, n (%) 260 (48.9)
Centre, n (%)
Belgian 127 (23.9)
British centre 135 (25.4)
Swiss centre 135 (25.4)
german centre 135 (25.4)
Type of stroke, n (%) 
Bleeding 76 (14.3)
Ischaemic infarct 446 (83.8)
Unknown 10 (1.9)
Urinary incontinence, n (%) 182 (34.2)
Swallowing problems, n (%) 106 (19.9)
Aphasia, n (%) 178 (33.5)
Dysarthria, n (%) 223 (41.9)
Cognitive impairment, n (%) 147 (27.6)
Diabetes mellitus, n (%) 118 (22.2)
history of hypertension, n (%) 354 (66.5)
Coronary heart disease, n (%) 135 (25.4)
Atrial fibrillation, n (%) 104 (19.6)
history of myocardial infarction, n (%) 68 (12.8)
hyperlipidaemia, n (%) 219 (41.2)
SD: standard deviation.
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ReSULTS
A total of 532 patients were included in CeRISe and in the 
present follow-up study. patients’ characteristics are shown in 
Table I. Mean follow-up time was 5.63 years (SD 0.63) (range: 
4.06–7.31). At the time of follow-up, 338 patients were alive; 
167 had died and 27 could not be contacted (Fig. 1). 
These 27 patients were known to be alive at 6 months post-
stroke and contributed to the kaplan–Meier calculations, 
with their survival time censored at 6 months post-stroke. 
Date of death was unknown for 4 patients. The midpoint of 
the interval between the moment they were last known to be 
alive and 5-year follow-up, was considered as date of death 
in the kaplan–Meier calculations. Table II shows the risk of 
death in each consecutive year. Five-year cumulative risk of 
death was 29.1%. 
Risk factors for long-term mortality after stroke (Table III)
Univariate analyses. Age (p < 0.0001), urinary incontinence 
(p < 0.0001), swallowing problems (p < 0.0001), aphasia 
(p = 0.04), dysarthria (p = 0.003), cognitive impairment 
(p < 0.0001), diabetes mellitus (p = 0.007), coronary heart dis-
ease (p < 0.0001), atrial fibrillation (p < 0.0001), and history of 
myocardial infarction (p = 0.02) were associated with increased 
mortality. hyperlipidaemia (p = 0.006) and higher initial BI 
score (p < 0.0001) were associated with decreased mortality. 
R2-values of parameters with significant associations ranged 
between 1.57% (aphasia) and 19.47% (age). 
Multivariate analysis. The vIF scores of all 17 baseline 
variables were low (range 1.07–2.34), indicating that the full 
model approach was appropriate. Independent predictors of 
increased mortality were age (p < 0.0001), cognitive impair-
ment (p = 0.003), diabetes mellitus (p = 0.006) and atrial fibril-
lation (p = 0.02). hyperlipidaemia (p = 0.02) was associated 
with reduced mortality. Urinary incontinence, swallowing 
problems, aphasia, dysarthria, coronary heart disease, his-
tory of myocardial infarction and initial BI score were not 
significant in the multivariate model (p > 0.05). R2 of the full 
model was 42.27%. 
Association between functional outcome 6 months post-stroke 
and long-term mortality.
BI6mths could not be assessed in 61 patients (Fig. 1). Baseline 
variables did not differ between the 61 drop-outs and 471 pa-
tients remaining in the study, except for swallowing problems 
(p = 0.02) and aphasia (p = 0.01). In the 471 patients, median 
BI6mths equalled 90 (IQR: 70–100). higher BI6mths-score 
was univariate significantly associated with decreased mortal-
ity (hR = 0.98, 95% CI: 0.97–0.98, p < 0.0001). R2 of BI6mths 
equalled 28.52%. Patients were classified into 3 classes based 
on their BI6mths-score: 106 patients (23%) were classified in 
the lowest (0–60), 131 (28%) in the middle (65–90) and 234 
(49%) in the highest class (95–100). kaplan–Meier curves for 
the 3 BI6mths classes are shown in Fig. 2. 
estimated 5-year survival probability was 0.85 (95% CI: 
0.80–0.89) for patients in BI6mths class 95–100, 0.72 (95% CI: 
0.63–0.79) in BI6mths class 65–90 and 0.50 (95% CI: 0.40–
0.60) in BI6mths class 0–60 (log-rank, p < 0.0001). BI6mths 
proved a significant independent predictor (p < 0.0001), after 
adding this parameter to the full model. 
Table II. Kaplan–Meier estimates of the risk of death within defined time intervals after stroke onset (n = 532)
years after stroke
< 1 1–< 2 2–< 3 3–< 4 4–< 5
At risk, n 522a 470a 448 423 368a
Deaths, n 42 22 25 32 31
Cumulative deaths, n 42 64 89 121 152b
Risk of death, % (95% CI) 8.05 (5.72–10.38) 4.68 (2.77–6.59) 5.58 (3.46–7.70) 7.57 (5.04–10.10) 8.42 (5.58–11.26)
Cumulative risk of death, % (95% CI) 8.05 (5.75–10.38) 12.26 (9.50–15.02) 17.05 (13.35–20.75) 23.18 (18.43–27.93) 29.12 (22.86–35.38)
a”Number at risk” is influenced by censored observations.
bAnother 15 patients died after 5 years.
CI: confidence interval.
Fig. 1. Study flowchart.
Baseline assessment on admission 
to the rehabilitation centre
532 stroke patients
Barthel ADL Index at six months 
after stroke onset
471 stroke patients
Vital status at five years after 
stroke onset
n=338, alive
n=163, died/known date of date
n=4, died/unknown date of death
n=27, lost-to-follow up/no contact 
information
n=37, refused assessment
n=20, died
n=2, moved <100 km away from 
the rehabilitation centre
n=1, coma
n=1, confidential
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DISCUSSION 
The main findings of this study are that nearly one-third of 
stroke rehabilitation patients died in the first 5 years following 
stroke; age, cognitive impairment, atrial fibrillation, and dia-
betes mellitus were independent predictors of increased mor-
tality, whereas hyperlipidaemia was associated with reduced 
long-term mortality after stroke; and a lower functional status 
at 6 months was both univariate and multivariate significantly 
associated with an increased long-term mortality.
The 5-year cumulative mortality risk of 29% was considera-
bly lower than that reported in the Framingham study (40–48%) 
(21), other community- and hospital-based studies (42–60%) 
(1–10), and the rehabilitation-based studies of Lincoln et al. 
Fig. 2. kaplan–Meier survival curves for stroke patients according to their functional status at 6 months after stroke onset (n = 471). BI6mths: Barthel 
Index at six months after stroke (0–100), log-rank test: p < 0.0001.
Table III. Univariate and multivariate Cox regression analyses of baseline predictors for long-term mortality after stroke (n = 532)
parameters
Univariate analysis
hR (95% CI) R2
Multivariate analysis
hR (95% CI)
Age at stroke onset 1.07 (1.05–1.09)*** 19.47 1.06 (1.04–1.09)***
Female gender 0.95 (0.70–1.29) 0.03 0.80 (0.56–1.11)
ever smoked 1.07 (0.79–1.45) 0.08 1.26 (0.89–1.78)
Centre 1.48
Belgian vs german centre 0.86 (0.54–1.37) 0.64 (0.38–1.07)
British vs german centre 1.30 (0.85–1.98) 0.80 (0.49–1.32)
Swiss vs german centre 1.19 (0.78–1.83) 0.80 (0.48–1.32)
Initial Barthel Index (0–100) 0.99 (0.98–0.99)*** 8.93 0.99 (0.98–1.00)
Type of stroke 0.73 (0.45–1.18) 0.62 0.91 (0.55–1.50)
Urinary incontinence 1.95 (1.44–2.65)*** 6.47 1.07 (0.68–1.70)
Swallowing problems 2.00 (1.43–2.80)*** 5.21 1.21 (0.81–1.82)
Aphasia 1.40 (1.02–1.91)* 1.57 1.00 (0.67–1.48)
Dysarthria 1.58 (1.17–2.14)** 3.14 1.07 (0.74–1.53)
Cognitive impairment 2.14 (1.57–2.92)*** 7.74 1.77 (1.21–2.57)**
Diabetes mellitus 1.58 (1.13–2.20)* 2.44 1.68 (1.16–2.41)**
history of hypertension 1.31 (0.93–1.83) 0.92 1.24 (0.86–1.80)
Coronary heart disease 1.90 (1.39–2.60)*** 5.32 1.46 (0.98–2.16)
Atrial fibrillation 2.35 (1.70–3.25)*** 8.56 1.52 (1.08–2.14)*
history of myocardial infarction 1.65 (1.10–2.47)* 1.87 1.20 (0.74–1.96)
hyperlipidaemia 0.60 (0.43–0.83)** 3.63 0.66 (0.46-0.94)*
*p < 0.05, **p < 0.01, ***p < 0.0001.
R2 full model: 42.27%.
HR: hazard ratio; CI: confidence interval; R²: explained variance according to formula of Royston.
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(45%) (11) and Indredavik et al. (59%) (12). This seems to 
be consistent as we recruited patients with a mean of 20 (SD 
9) days post-stroke. hence, we did not observe the high acute 
mortality rate in the first critical days, as observed in com-
munity and hospital-based studies (1–10) and by Indredavik 
et al. (12) who recruited patients from a combined acute- and 
rehabilitation stroke unit. Moreover, in the majority of the re-
ported studies (1–4, 6–8, 10–12), patients were recruited in the 
late 1980s and early 1990s. There are indications that survival 
rate after stroke has increased since the 1990s, probably due 
to better stroke prevention strategies (13).
In line with community- and hospital-based studies (3, 6, 7, 
9, 10), we found that age, diabetes mellitus, and atrial fibrilla-
tion were independently associated with long-term mortality 
post-stroke. The association with cognitive impairment has 
been investigated in two other studies, with conflicting findings 
(3, 8). hyperlipidaemia was associated with reduced long-term 
mortality, which is in line with the findings of another study 
(22). This opposite finding may simply indicate that a low cho-
lesterol level is associated with increased long-term mortality. 
It is possible that lower cholesterol in these relatively elderly 
patients may reflect underlying illness and poor nutritional 
status, which could predispose to a poor outcome after stroke. 
In future studies, the complex association between cholesterol 
level and mortality after stroke needs further attention. 
For certain variables, hRs differed drastically between uni-
variate and multivariate analysis. Urinary incontinence, swal-
lowing problems, aphasia and dysarthria can each be considered 
as an indicator for stroke severity, as is the initial Barthel Index. 
Their HRs became insignificant in the multivariate model where 
initial Barthel Index was presented with a borderline significance 
of p = 0.06 (p-value is not shown in results). The same was true 
for coronary heart disease and history of myocardial infarction 
on the one hand and patients’ age on the other hand. Finally, 
hR altered drastically in the between-centre comparisons. hR 
(“British vs german centre”) and hR (“Swiss vs german cen-
tre”) indicate that, although not significant, the risk of dying 
was higher (hR > 1) in patients from British and Swiss centres 
compared with the german patients in univariate analysis. The 
opposite (hR > 1) was true in the multivariate analysis. patients 
in both the British and Swiss centre were significantly older 
compared with patients in the german centre (14). Age is an 
important predictor of mortality, explaining the higher risk of 
dying for patients in the Swiss and german centre (hR >1 in 
univariate analysis). When including age into the multivariate 
model, this effect disappeared.
Finally, we found a strong association between low func-
tional status 6 months post-stroke and increased long-term 
mortality. The univariate predictive value of BI6mths was 
28.5%. This was considerably higher than any baseline 
variable, making it the most important observed univariate 
predictor. In multivariate analysis, BI6mths remained signifi-
cantly associated with long-term mortality. These findings are 
consistent with other studies (9, 13). In a community-based 
study, Slot et al. (13) found a significant association between 
a higher modified Rankin scale (mRS) (more dependency) at 
6 months and an increased risk of death. In a hospital-based 
study, eriksson et al. (9) found that the mRS at 3 months was 
a significant independent predictor for long-term survival. The 
present study indicates that the association between functional 
disability and survival was also present in a sample of stroke 
patients who received inpatient rehabilitation. Based on a meta-
analysis, kwakkel et al. (23) reported that minimum 16 h of 
additional exercise therapy time is required in the first 6 months 
after stroke to obtain a significant 4–5% improvement in in-
dependency for activities of daily living, reflecting a 5-point 
increase (5%) in BI-outcome. Applying this to the current study 
sample, a 5% increase in BI6mths-score would produce a shift 
of 36 patients (7% of total group) to a higher BI6mths class 
and an accompanying increasing survival chance. Twenty-one 
percent (n = 28) of patients in the middle class would shift to 
the highest BI6mths class, potentially increasing their 5-year 
survival probability from 0.72 to 0.85. eight percent of patients 
in the lowest class would shift to the middle BI6mths class, 
potentially increasing their 5-year survival probability from 
0.50 to 0.71. Of note, the effect of rehabilitation on survival 
as such was not evaluated in the present study. Future trials 
should focus on the effect of additional exercise therapy time 
on functional outcome and survival.
The importance of our study rests upon the fact that we 
studied stroke patients who received inpatient rehabilita-
tion. The long-term survival of this specific patient group 
has received little attention, which is surprising given the 
healthcare resources consumed by inpatient stroke care. To 
our knowledge, the current patient sample is larger than any 
other rehabilitation-based study reporting long-term mortality 
after stroke (11, 12). patients were recruited from 4 european 
rehabilitation centres that were selected because of their es-
tablished reputation for stroke rehabilitation. Baseline data 
are detailed and complete. Follow-up was prospective with 
minimal drop-out at 6 months and 5 years post-stroke. To 
investigate the association between 6 months functional status 
and mortality, we could not include 61 patients. Swallowing 
problems and aphasia occurred significantly more in the drop-
out group. Both parameters were significant in univariate, but 
not in multivariate Cox regression analysis. We believe that 
the exclusion of these 61 patients is not substantially influenc-
ing our findings regarding the effect of 6 months functional 
status on long-term mortality. In addition, a crude sensitivity 
analysis (i.e. single imputation of BI6mths values) resulted in 
only marginally different results that did not alter any of the 
conclusions. This is reassuring and strengthens our findings. 
In large cohort studies, weak associations may become sig-
nificant due to the large sample size. The explained variance 
(R²) indicates the strength/weakness of the association between 
the independent and dependent variable and puts results into 
perspective. R2 of the full model was 42.27%, indicating that 
approximately 58% of the variation in mortality in the first 5 
years after stroke was not explained by the baseline model. This 
unexplained variance may be attributed to unmeasured baseline 
factors (e.g. cancer) and factors that developed after baseline 
(e.g. co-morbidities, extent of secondary prevention, etc.). In 
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previous studies, R2 was not reported preventing comparison 
(2, 3, 6, 7, 9, 10). The lack of detailed medical information is 
a limitation of the study. No detailed information was available 
on type of medication, blood cholesterol levels, or cognitive 
impairment. We considered patients to have hyperlipidaemia if 
blood cholesterol concentration > 200 mg/100ml, based upon 
a single blood measurement on admission. Serum cholesterol 
levels in blood samples taken in the morning from fasting 
patients are more reliable for diagnosis. NIhSS was used to 
define cognitive impairment. In addition, we were unable to 
document recurrent strokes in the deceased patients.
In conclusion, nearly one-third of stroke rehabilitation pa-
tients died during the first 5 years following stroke. Functional 
status at 6 months was a powerful predictor of long-term mor-
tality. Interventions that improve post-stroke functional status 
may have a protective effect on mortality. Maximum functional 
independence at 6 months post-stroke should therefore be pro-
moted through medical interventions and rehabilitation. Future 
trials to investigate the effect of additional exercise therapy 
time on functional outcome and survival are recommended.
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